ミトコンドリア内葉酸代謝酵素を標的としたがん治療

DOI オープンアクセス
  • 西村 建徳
    金沢大学　がん進展制御研究所　分子病態研究分野
  • Jin Lee
    金沢大学　がん進展制御研究所　分子病態研究分野
  • Xiaoxi Chen
    金沢大学　がん進展制御研究所　分子病態研究分野
  • 東條 有伸
    東京大学　医科学研究所　先端医療研究センター　分子療法分野
  • 後藤 典子
    金沢大学　がん進展制御研究所　分子病態研究分野

書誌事項

タイトル別名
  • Cancer treatments targeting mitochondrial enzymes involved in one-carbon metabolism

この論文をさがす

抄録

<p>One-carbon metabolism, also called folate-mediated metabolism, has been targeted for the treatment of patients with cancer. However, therapeutic windows available to the inhibitors of one-carbon metabolism are limited and some patients have been shown to develop resistance to anti-folate drugs. Recently, we showed that mitochondrial enzymes involved in one-carbon metabolism have greater specifi city toward cancer cells than the cytoplasmic enzymes. In our study, we knocked down the methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2, methenyltetrahydrofolate cyclohydrolase (MTHFD2) gene in order to inhibit the activity of one such mitochondrial enzyme. Cell cycle progression was analyzed using propidium iodide, and stem cell-like nature was evaluated in terms of aldehyde dehydrogenase activity on a fl ow cytometric setup. Our results showed a drastic decrease in cellular proliferation and stem cell-like phenotypes in the MTHFD2 knockdown cells. From a mechanistic point of view, the inhibition of cellular growth could be predominantly ascribed to the depletion of purine nucleotides, and that of stem cell-like phenotypes was attributable to the accumulation of 1-(5'-phosphoribosyl)-5-amino-4- imidazolecarboxamide.</p>

収録刊行物

関連プロジェクト

もっと見る

キーワード

詳細情報 詳細情報について

問題の指摘

ページトップへ